Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 71Leukemia, Lymphocytic, Chronic, B-Cell 62Hodgkin Disease 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Myelodysplastic Syndromes 56Lymphoma, Non-Hodgkin 54Multiple Myeloma 52Leukemia 43Lymphoma, Mantle-Cell 40Lymphoma 39Lymphoma, Large B-Cell, Diffuse 37Leukemia, Myelogenous, Chronic, BCR-ABL Positive 37Myeloproliferative Disorders 36Lymphoma, Follicular 36Lymphoma, B-Cell, Marginal Zone 33Leukemia, Myelomonocytic, Chronic 28Burkitt Lymphoma 28Congenital Abnormalities 27Anemia, Refractory, with Excess of Blasts 25Waldenstrom Macroglobulinemia 24Lymphoma, Large-Cell, Immunoblastic 24Leukemia, Myeloid, Chronic-Phase 24Hematologic Neoplasms 23Primary Myelofibrosis 22Leukemia, Myeloid, Accelerated Phase 20Blast Crisis 19Graft vs Host Disease 18Neoplasms, Plasma Cell 17Leukemia, Prolymphocytic 17Leukemia, Myelomonocytic, Juvenile 17

Interventions

thymoglobulin 1Mycophenolic Acid 1Cyclosporine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neural Tube Defects × Mycophenolic Acid × Clear all
NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡